{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:02:40Z","timestamp":1771063360366,"version":"3.50.1"},"reference-count":115,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Hepatitis C Virus (HCV) is a global health concern, chronically infecting over 70 million people worldwide. HCV is a bloodborne pathogen that primarily affects the liver, and chronic\nHCV infection can lead to cirrhosis, liver cancer, and liver failure over time. There is an urgent\nneed for more effective approaches to prevent and treat HCV. This review summarizes current\nknowledge on the virology, transmission, diagnosis, and management of HCV infection. It also\nprovides an in-depth analysis of HCV proteins as promising targets for antiviral drug and vaccine\ndevelopment. Specific HCV proteins discussed as potential drug targets include the NS5B polymerase, NS3\/4A protease, entry receptors like CD81, and core proteins. The implications of HCV\nproteins as diagnostic and prognostic biomarkers are also explored. Current direct-acting antiviral\ntherapies are effective but have cost, genotype specificity, and resistance limitations. This review\naims to synthesize essential information on HCV biology and pathogenesis to inform future research on improved preventive, diagnostic, and therapeutic strategies against this global infectious\ndisease threat.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113894501265769231020031857","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T04:04:36Z","timestamp":1698811476000},"page":"1127-1138","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An Insight into Hepatitis C Virus: In Search of Promising Drug Targets"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5217-9039","authenticated-orcid":true,"given":"Manish","family":"Dwivedi","sequence":"first","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus, Gomtinagar Extension, Lucknow-\n226028, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Dwivedi","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus, Gomtinagar Extension, Lucknow-\n226028, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debalina","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Zoology, West Bengal State University, W.B., India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"McGlynn KA","year":"2021","unstructured":"McGlynn KA; Petrick JL; El-Serag HB; Epidemiology of hepatocellular carcinoma. Hepatology 2021,73(S1),4-13","journal-title":"Hepatology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"794","DOI":"10.2174\/1389450116666150825112105","volume":"18","author":"Giuggioli D.","year":"2017","unstructured":"Giuggioli D.; Sebastiani M.; Colaci M.; Fallahi P.; Gragnani L.; Zignego A.L.; Antonelli A.; Ferri C.; Treatment of HCV-related mixed cryoglobulinemia. Curr Drug Targets 2017,18(7),794-802","journal-title":"Curr Drug Targets"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e23755","DOI":"10.1002\/jcla.23755","volume":"35","author":"Wang Y.","year":"2021","unstructured":"Wang Y.; Jie W.; Ling J.; Yuanshuai H.; HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection. J Clin Lab Anal 2021,35(6),e23755","journal-title":"J Clin Lab Anal"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/14737159.2017.1293526","volume":"17","author":"Kessler H.H.","year":"2017","unstructured":"Kessler H.H.; Stelzl E.; Profile of Roche\u2019s cobas HCV tests. Expert Rev Mol Diagn 2017,17(4),311-319","journal-title":"Expert Rev Mol Diagn"},{"key":"ref=5","author":"Lavie M.","year":"2006","unstructured":"Lavie M.; Goffard A.; Dubuisson J.; HCV glycoproteins: Assembly of a functional E1\u2013E2 heterodimer. Hepatitis C Viruses: Genomes and Molecular Biology 2006","journal-title":"Hepatitis C Viruses: Genomes and Molecular Biology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-3-642-27340-7_4","volume":"369","author":"Zeisel M.B.","year":"2013","unstructured":"Zeisel M.B.; Felmlee D.J.; Baumert T.F.; Hepatitis C virus entry. Curr Top Microbiol Immunol 2013,369,87-112","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/v9080224","volume":"9","author":"Chan S.","year":"2017","unstructured":"Chan S.; Ou J.; Hepatitis C.; Hepatitis C virus-induced autophagy and host innate immune response. Viruses 2017,9(8),224","journal-title":"Viruses"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1128\/CDLI.9.6.1385-1388.2002","volume":"9","author":"Kessler H.H.","year":"2002","unstructured":"Kessler H.H.; Clarici A.M.K.; Stelzl E.; M\u00fchlbauer G.; Daghofer E.; Santner B.I.; Marth E.; Stauber R.E.; Fully automated detection of hepatitis C virus RNA in serum and whole-blood samples. Clin Vaccine Immunol 2002,9(6),1385-1388","journal-title":"Clin Vaccine Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-642-27340-7_5","volume":"369","author":"Moradpour D.","year":"2013","unstructured":"Moradpour D.; Penin F.; Hepatitis C virus proteins: From structure to function. Curr Top Microbiol Immunol 2013,369,113-142","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-27340-7_1","volume":"369","author":"Simmonds P.","year":"2013","unstructured":"Simmonds P.; The origin of hepatitis C virus. Curr Top Microbiol Immunol 2013,369,1-15","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1515\/hsz-2015-0172","volume":"396","author":"Wang L.","year":"2015","unstructured":"Wang L.; James Ou J.; Hepatitis C virus and autophagy. Biol Chem 2015,396(11),1215-1222","journal-title":"Biol Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3748\/wjg.v13.i17.2406","volume":"13","author":"Dubuisson J.","year":"2007","unstructured":"Dubuisson J.; Hepatitis C virus proteins. World J Gastroenterol 2007,13(17),2406-2415","journal-title":"World J Gastroenterol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1140-4639(05)80118-2","volume":"35","author":"Janot C","year":"1992","unstructured":"Janot C; Botte C; Hepatitis C virus. Rev Fr Transfus Hemobiol 1992,35(3),155-62","journal-title":"Rev Fr Transfus Hemobiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3390\/v3112238","volume":"3","author":"Popescu C.I.","year":"2011","unstructured":"Popescu C.I.; Rouill\u00e9 Y.; Dubuisson J.; Hepatitis C virus assembly imaging. Viruses 2011,3(11),2238-2254","journal-title":"Viruses"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"007","DOI":"10.1055\/s-0034-1371178","volume":"34","author":"Pawlotsky J.M.","year":"2014","unstructured":"Pawlotsky J.M.; New hepatitis C therapies. Semin Liver Dis 2014,34(1),007-008","journal-title":"Semin Liver Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.3748\/wjg.v20.i29.9633","volume":"20","author":"Ansaldi F.","year":"2014","unstructured":"Ansaldi F.; Orsi A.; Sticchi L.; Bruzzone B.; Icardi G.; Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World J Gastroenterol 2014,20(29),9633-9652","journal-title":"World J Gastroenterol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"15992","DOI":"10.3748\/wjg.v20.i43.15992","volume":"20","author":"Preciado M.V.","year":"2014","unstructured":"Preciado M.V.; Valva P.; Escobar-Gutierrez A.; Rahal P.; Ruiz-Tovar K.; Yamasaki L.; Vazquez-Chacon C.; Martinez-Guarneros A.; Carpio-Pedroza J.C.; Fonseca-Coronado S.; Cruz-Rivera M.; Hepatitis C virus molecular evolution: Transmission, disease progression and antiviral therapy. World J Gastroenterol 2014,20(43),15992-16013","journal-title":"World J Gastroenterol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.3748\/wjg.v19.i44.7896","volume":"19","author":"Irshad M.","year":"2013","unstructured":"Irshad M.; Mankotia D.S.; Irshad K.; An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World J Gastroenterol 2013,19(44),7896-7909","journal-title":"World J Gastroenterol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3748\/wjg.v17.i20.2507","volume":"17","author":"Osna N.A.","year":"2011","unstructured":"Osna N.A.; Thomes P.G.; Donohue T.M.; Involvement of autophagy in alcoholic liver injury and hepatitis C pathogenesis. World J Gastroenterol 2011,17(20),2507-2514","journal-title":"World J Gastroenterol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.5152\/tjg.2020.18798","volume":"31","author":"\u00c7etin Duran A.","year":"2020","unstructured":"\u00c7etin Duran A.; Kaya \u00c7etinkaya O.; Sayiner A.A.; \u015eeydao\u011flu G.; \u00d6zkarata\u015f E.; Abac\u0131o\u011flu H.; Changes on Hepatitis C virus genotype distribution in Western Turkey: Evaluation of twelve-year data. Turk J Gastroenterol 2020,31(2),128-135","journal-title":"Turk J Gastroenterol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12985-018-1017-4","volume":"15","author":"Warkad S.D.","year":"2018","unstructured":"Warkad S.D.; Nimse S.B.; Song K.S.; Chantratita W.; Pongthanapisith V.; Nawale L.U.; Kim T.; Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples. Virol J 2018,15(1),107","journal-title":"Virol J"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.3390\/v14112570","volume":"14","author":"Fabrizi F.","year":"2022","unstructured":"Fabrizi F.; Tripodi F.; Cerutti R.; Nardelli L.; Alfieri C.M.; Donato M.F.; Castellano G.; Recent information on pan-genotypic direct-acting antiviral agents for hcv in chronic kidney disease. Viruses 2022,14(11),2570","journal-title":"Viruses"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells8040376","volume":"8","author":"Chigbu D.","year":"2019","unstructured":"Chigbu D.; Loonawat R.; Sehgal M.; Patel D.; Jain P.; Hepatitis C.; Hepatitis C virus infection: Host\u2013virus interaction and mechanisms of viral persistence. Cells 2019,8(4),376","journal-title":"Cells"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"105419","DOI":"10.1016\/j.antiviral.2022.105419","volume":"207","author":"Ma L.","year":"2022","unstructured":"Ma L.; Li Q.; Xie Y.; jianyuan Zhao ; Yi D.; Guo S.; Guo F.; Wang J.; Yang L.; Cen S.; Repurposing of HIV\/HCV protease inhibitors against SARS-CoV-2 3CL. Antiviral Res 2022,207,105419","journal-title":"Antiviral Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12026-014-8494-3","volume":"60","author":"Gawlik K.","year":"2014","unstructured":"Gawlik K.; Gallay P.A.; HCV core protein and virus assembly: What we know without structures. Immunol Res 2014,60(1),1-10","journal-title":"Immunol Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1007\/s12094-022-02859-y","volume":"24","author":"Wang X.","year":"2022","unstructured":"Wang X.; Zhou Y.; Wang C.; Zhao Y.; Cheng Y.; Yu S.; Li X.; Zhang W.; Zhang Y.; Quan H.; HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt\/\u03b2-catenin signaling pathway during the progression of HCC. Clin Transl Oncol 2022,24(10),1998-2009","journal-title":"Clin Transl Oncol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3748\/wjg.v22.i6.1953","volume":"22","author":"Grassi G.","year":"2016","unstructured":"Grassi G.; Di Caprio G.; Fimia G.M.; Ippolito G.; Tripodi M.; Alonzi T.; Hepatitis C virus relies on lipoproteins for its life cycle. World J Gastroenterol 2016,22(6),1953-1965","journal-title":"World J Gastroenterol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.addr.2007.04.014","volume":"59","author":"Suzuki T.","year":"2007","unstructured":"Suzuki T.; Ishii K.; Aizaki H.; Wakita T.; Hepatitis C viral life cycle. Adv Drug Deliv Rev 2007,59(12),1200-1212","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3390\/ijms21041479","volume":"21","author":"Romero-L\u00f3pez C.","year":"2020","unstructured":"Romero-L\u00f3pez C.; Berzal-Herranz A.; The Role of the RNA-RNA Interactome in the Hepatitis C Virus Life Cycle. Int J Mol Sci 2020,21(4),1479","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.bbapap.2015.04.011","volume":"1854","author":"Colpitts C.C.","year":"2015","unstructured":"Colpitts C.C.; Lupberger J.; Doerig C.; Baumert T.F.; Host cell kinases and the hepatitis C virus life cycle. Biochim Biophys Acta Proteins Proteomics 2015,1854(10),1657-1662","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.18388\/abp.2007_3138","volume":"54","author":"Rych\u0142owska M.","year":"2007","unstructured":"Rych\u0142owska M.; Bie\u0144kowska-Szewczyk K.; Hepatitis C--new developments in the studies of the viral life cycle. Acta Biochim Pol 2007,54(4),703-715","journal-title":"Acta Biochim Pol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/v5051292","volume":"5","author":"Felmlee D.","year":"2013","unstructured":"Felmlee D.; Hafirassou M.; Lefevre M.; Baumert T.; Schuster C.; Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. Viruses 2013,5(5),1292-1324","journal-title":"Viruses"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.cmi.2016.08.025","volume":"22","author":"Dustin L.B.","year":"2016","unstructured":"Dustin L.B.; Bartolini B.; Capobianchi M.R.; Pistello M.; Hepatitis C virus: Life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy. Clin Microbiol Infect 2016,22(10),826-832","journal-title":"Clin Microbiol Infect"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jhep.2014.06.031","volume":"61","author":"Dubuisson J.","year":"2014","unstructured":"Dubuisson J.; Cosset F.L.; Virology and cell biology of the hepatitis C virus life cycle \u2013 An update. J Hepatol 2014,61(1),S3-S13","journal-title":"J Hepatol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"a037069","DOI":"10.1101\/cshperspect.a037069","volume":"9","author":"Houghton M.","year":"2019","unstructured":"Houghton M.; Hepatitis C.; Hepatitis C Virus: 30 Years after Its Discovery. Cold Spring Harb Perspect Med 2019,9(12),a037069","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","volume":"3","author":"Manns M.P.","year":"2017","unstructured":"Manns M.P.; Buti M.; Gane E.; Pawlotsky J.M.; Razavi H.; Terrault N.; Younossi Z.; Hepatitis C virus infection. Nat Rev Dis Primers 2017,3(1),17006","journal-title":"Nat Rev Dis Primers"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.3748\/wjg.v27.i28.4555","volume":"27","author":"Li H.C.","year":"2021","unstructured":"Li H.C.; Yang C.H.; Lo S.Y.; Cellular factors involved in the hepatitis C virus life cycle. World J Gastroenterol 2021,27(28),4555-4581","journal-title":"World J Gastroenterol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/v13030520","volume":"13","author":"Li H.C.","year":"2021","unstructured":"Li H.C.; Yang C.H.; Lo S.Y.; Hepatitis C.; Hepatitis C viral replication complex. Viruses 2021,13(3),520","journal-title":"Viruses"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1002\/lt.21644","volume":"14","author":"Ram\u00edrez S.","year":"2008","unstructured":"Ram\u00edrez S.; P\u00e9rez-del-Pulgar S.; Forns X.; Virology and pathogenesis of hepatitis C virus recurrence. Liver Transpl 2008,14(S2),S27-S35","journal-title":"Liver Transpl"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/v7031153","volume":"7","author":"Rossi L.","year":"2015","unstructured":"Rossi L.; Escobar-Gutierrez A.; Rahal P.; Advanced molecular surveillance of hepatitis C virus. Viruses 2015,7(3),1153-1188","journal-title":"Viruses"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/23744235.2017.1300682","volume":"49","author":"Lagging M.","year":"2017","unstructured":"Lagging M.; Wejst\u00e5l R.; Norkrans G.; Karlstr\u00f6m O.; Aleman S.; Weiland O.; Castedal M.; Westin J.; Treatment of hepatitis C virus infection: Updated Swedish Guidelines 2016. Infect Dis 2017,49(8),561-575","journal-title":"Infect Dis"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0950-3528(96)90006-8","volume":"10","author":"Booth J.C.L.","year":"1996","unstructured":"Booth J.C.L.; Thomas H.C.; Pathogenesis of chronic hepatitis C and associated clinical manifestations. Baillieres Clin Gastroenterol 1996,10(2),257-274","journal-title":"Baillieres Clin Gastroenterol"},{"key":"ref=43","first-page":"36","volume":"41","author":"Willems M.","year":"1992","unstructured":"Willems M.; Moshage H.; Fevery J.; Yap S.H.; Hepatitis C.; Hepatitis C. Neth J Med 1992,41(1-2),36-43","journal-title":"Neth J Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40265-016-0685-x","volume":"77","author":"Chan A.","year":"2017","unstructured":"Chan A.; Patel K.; Naggie S.; Genotype 3 infection: The last stand of hepatitis C Virus. Drugs 2017,77(2),131-144","journal-title":"Drugs"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1186\/s12864-017-4267-4","volume":"18","author":"Campo D.S.","year":"2017","unstructured":"Campo D.S.; Zhang J.; Ramachandran S.; Khudyakov Y.; Transmissibility of intra-host hepatitis C virus variants. BMC Genomics 2017,18(S10),881","journal-title":"BMC Genomics"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1111\/j.1742-4658.2007.06017.x","volume":"274","author":"R\u00e9geard M.","year":"2007","unstructured":"R\u00e9geard M.; Lep\u00e8re C.; Trotard M.; Gripon P.; Le Seyec J.; Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle. FEBS J 2007,274(18),4705-4718","journal-title":"FEBS J"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1248\/bpb.33.355","volume":"33","author":"Fukasawa M.","year":"2010","unstructured":"Fukasawa M.; Cellular lipid droplets and hepatitis C virus life cycle. Biol Pharm Bull 2010,33(3),355-359","journal-title":"Biol Pharm Bull"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3748\/wjg.v22.i4.1421","volume":"22","author":"Gonz\u00e1lez-Grande R.","year":"2016","unstructured":"Gonz\u00e1lez-Grande R.; Jim\u00e9nez-P\u00e9rez M.; Gonz\u00e1lez Arjona C.; Mostazo Torres J.; New approaches in the treatment of hepatitis C. World J Gastroenterol 2016,22(4),1421-1432","journal-title":"World J Gastroenterol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/2211068214563794","volume":"20","author":"Mukherjee R.","year":"2015","unstructured":"Mukherjee R.; Burns A.; Rodden D.; Chang F.; Chaum M.; Garcia N.; Bollipalli N.; Niemz A.; Diagnosis and management of hepatitis C Virus infection. SLAS Technol 2015,20(5),519-538","journal-title":"SLAS Technol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0149-2918(96)80193-7","volume":"18","author":"Simmonds P.","year":"1996","unstructured":"Simmonds P.; Virology of hepatitis C virus. Clin Ther 1996,18(Suppl B),9-36","journal-title":"Clin Ther"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1586\/eri.09.12","volume":"7","author":"Meier V.","year":"2009","unstructured":"Meier V.; Ramadori G.; Hepatitis C virus virology and new treatment targets. Expert Rev Anti Infect Ther 2009,7(3),329-350","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S1471-4914(02)02395-X","volume":"8","author":"Moradpour D.","year":"2002","unstructured":"Moradpour D.; Brass V.; Gosert R.; W\u00f6lk B.; Blum H.E.; Hepatitis C: Molecular virology and antiviral targets. Trends Mol Med 2002,8(10),476-482","journal-title":"Trends Mol Med"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.3748\/wjg.v13.i17.2461","volume":"13","author":"Chevaliez S.","year":"2007","unstructured":"Chevaliez S.; Pawlotsky J.M.; Hepatitis C virus: Virology, diagnosis and management of antiviral therapy. World J Gastroenterol 2007,13(17),2461-2466","journal-title":"World J Gastroenterol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coviro.2020.10.002","volume":"46","author":"Stuart J.D.","year":"2021","unstructured":"Stuart J.D.; Salinas E.; Grakoui A.; Immune system control of hepatitis C virus infection. Curr Opin Virol 2021,46,36-44","journal-title":"Curr Opin Virol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/v14020308","volume":"14","author":"Werling K.","year":"2022","unstructured":"Werling K.; Hunyady B.; Makara M.; Nemesi K.; Horv\u00e1th G.; Schneider F.; Enyedi J.; M\u00fcller Z.; Lesch M.; P\u00e9terfi Z.; T\u00f3th T.; G\u00e1cs J.; Feh\u00e9r Z.; Ujhelyi E.; Moln\u00e1r E.; Nemes Nagy A.; Hepatitis C.; Hepatitis C screening and treatment program in hungarian prisons in the era of direct acting antiviral agents. Viruses 2022,14(2),308","journal-title":"Viruses"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/14789450.2017.1344102","volume":"14","author":"Crouchet E.","year":"2017","unstructured":"Crouchet E.; Baumert T.F.; Schuster C.; Hepatitis C virus\u2013apolipoprotein interactions: Molecular mechanisms and clinical impact. Expert Rev Proteomics 2017,14(7),593-606","journal-title":"Expert Rev Proteomics"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3350\/cmh.2015.21.2.105","volume":"21","author":"Goossens N.","year":"2015","unstructured":"Goossens N.; Hoshida Y.; Hepatitis C virus-induced hepatocellular carcinoma. Clin Mol Hepatol 2015,21(2),105-114","journal-title":"Clin Mol Hepatol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.meegid.2013.10.021","volume":"21","author":"Jackowiak P.","year":"2014","unstructured":"Jackowiak P.; Kuls K.; Budzko L.; Mania A.; Figlerowicz M.; Figlerowicz M.; Phylogeny and molecular evolution of the hepatitis C virus. Infect Genet Evol 2014,21,67-82","journal-title":"Infect Genet Evol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0891-5520(05)70405-0","volume":"12","author":"Alter M.J.","year":"1998","unstructured":"Alter M.J.; Mast E.E.; Moyer L.A.; Margolis H.S.; Hepatitis C.; Hepatitis C. Infect Dis Clin North Am 1998,12(1),13-26","journal-title":"Infect Dis Clin North Am"},{"key":"ref=60","first-page":"198","volume":"64","author":"Chalupa P","year":"2015","unstructured":"Chalupa P; Holub M; Davidov\u00e1 A; Arientov\u00e1 S; Beran O; Immune response in the pathogenesis of hepatitis C virus infection. Epidemiol Mikrobiol Imunol 2015,64(4),198-203","journal-title":"Epidemiol Mikrobiol Imunol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2893.1997.tb00178.x","volume":"4","author":"Koziel M.J.","year":"1997","unstructured":"Koziel M.J.; The role of immune responses in the pathogenesis of hepatitis C virus infection. J Viral Hepat 1997,4(s2),31-41","journal-title":"J Viral Hepat"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0966-842X(99)01590-5","volume":"7","author":"Forns X.","year":"1999","unstructured":"Forns X.; Purcell R.H.; Bukh J.; Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol 1999,7(10),402-410","journal-title":"Trends Microbiol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"13034","DOI":"10.1073\/pnas.96.23.13034","volume":"96","author":"Bressanelli S.","year":"1999","unstructured":"Bressanelli S.; Tomei L.; Roussel A.; Incitti I.; Vitale R.L.; Mathieu M.; De Francesco R.; Rey F.A.; Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci USA 1999,96(23),13034-13039","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22159\/ijpps.2016v8i11.13965","volume":"8","author":"Polamreddy P.","year":"2016","unstructured":"Polamreddy P.; Vishwakarma V.; Gundla R.; a review on anti-hcv agents targeting active site and allosteric sites of non-structural protein 5b [NS5B]. Int J Pharm Pharm Sci 2016,8(11),1-18","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.bmcl.2019.03.037","volume":"29","author":"Taylor J.G.","year":"2019","unstructured":"Taylor J.G.; Zipfel S.; Ramey K.; Vivian R.; Schrier A.; Karki K.K.; Katana A.; Kato D.; Kobayashi T.; Martinez R.; Sangi M.; Siegel D.; Tran C.V.; Yang Z.Y.; Zablocki J.; Yang C.Y.; Wang Y.; Wang K.; Chan K.; Barauskas O.; Cheng G.; Jin D.; Schultz B.E.; Appleby T.; Villase\u00f1or A.G.; Link J.O.; Discovery of the pan-genotypic hepatitis C virus NS3\/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi. Bioorg Med Chem Lett 2019,29(16),2428-2436","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.3748\/wjg.v13.i36.4808","volume":"13","author":"Timm J.","year":"2007","unstructured":"Timm J.; Roggendorf M.; Sequence diversity of hepatitis C virus: Implications for immune control and therapy. World J Gastroenterol 2007,13(36),4808-4817","journal-title":"World J Gastroenterol"},{"key":"ref=67","first-page":"1429","volume":"156","author":"Krarup HB","year":"1994","unstructured":"Krarup HB; Krogsgaard K; Hepatitis C. Ugeskr Laeger 1994,156(28),1429-34","journal-title":"Ugeskr Laeger"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.3748\/wjg.v20.i23.7104","volume":"20","author":"Li H.C.","year":"2014","unstructured":"Li H.C.; Ma H.C.; Yang C.H.; Lo S.Y.; Production and pathogenicity of hepatitis C virus core gene products. World J Gastroenterol 2014,20(23),7104-7122","journal-title":"World J Gastroenterol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4414\/smw.2001.06097","volume":"131","author":"Moradpour D.","year":"2001","unstructured":"Moradpour D.; Cerny A.; Heim M.H.; Blum H.E.; Hepatitis C: An update. Swiss Med Wkly 2001,131(21-22),291-298","journal-title":"Swiss Med Wkly"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2893.1994.tb00057.x","volume":"1","author":"Dusheiko G.","year":"1994","unstructured":"Dusheiko G.; Simmonds P.; Sequence variability of hepatitis C virus and its clinical relevance. J Viral Hepat 1994,1(1),3-15","journal-title":"J Viral Hepat"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.micpath.2013.02.005","volume":"58","author":"Fauvelle C.","year":"2013","unstructured":"Fauvelle C.; Lepiller Q.; Felmlee D.J.; Fofana I.; Habersetzer F.; Stoll-Keller F.; Baumert T.F.; Fafi-Kremer S.; Hepatitis C virus vaccines \u2013 Progress and perspectives. Microb Pathog 2013,58,66-72","journal-title":"Microb Pathog"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1586\/14737159.5.4.507","volume":"5","author":"Weck K.","year":"2005","unstructured":"Weck K.; Molecular methods of hepatitis C genotyping. Expert Rev Mol Diagn 2005,5(4),507-520","journal-title":"Expert Rev Mol Diagn"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3748\/wjg.v22.i4.1477","volume":"22","author":"Zhou L.Y.","year":"2016","unstructured":"Zhou L.Y.; Zhang L.L.; Host restriction factors for hepatitis C virus. World J Gastroenterol 2016,22(4),1477-1486","journal-title":"World J Gastroenterol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3748\/wjg.v20.i10.2624","volume":"20","author":"Ruggieri V.","year":"2014","unstructured":"Ruggieri V.; Mazzoccoli C.; Pazienza V.; Andriulli A.; Capitanio N.; Piccoli C.; Hepatitis C virus, mitochondria and auto\/mitophagy: Exploiting a host defense mechanism. World J Gastroenterol 2014,20(10),2624-2633","journal-title":"World J Gastroenterol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1080\/17425255.2016.1209484","volume":"12","author":"Esposito I.","year":"2016","unstructured":"Esposito I.; Trinks J.; Soriano V.; Hepatitis C virus resistance to the new direct-acting antivirals. Expert Opin Drug Metab Toxicol 2016,12(10),1197-1209","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/08820139709048927","volume":"26","author":"Nolte F.S.","year":"1997","unstructured":"Nolte F.S.; Laboratory diagnosis of hepatitis C. Immunol Invest 1997,26(1-2),199-207","journal-title":"Immunol Invest"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"483","DOI":"10.15537\/smj.2016.5.14178","volume":"37","author":"Du L.","year":"2016","unstructured":"Du L.; Tang H.; An insight into the molecular characteristics of hepatitis C virus for clinicians. Saudi Med J 2016,37(5),483-491","journal-title":"Saudi Med J"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3760\/cma.j.issn.1007-3418.2019.12.008","volume":"27","year":"2019","unstructured":"Guidelines for the prevention and treatment of hepatitis C. Zhonghua Gan Zang Bing Za Zhi Chinese Society of Infectious Diseases, Chinese Medical Association2019,27(12),962-979","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcv.2004.10.005","volume":"32","author":"Seme K.","year":"2005","unstructured":"Seme K.; Poljak M.; Babi\u010d D.Z.; Mo\u010dilnik T.; Vince A.; The role of core antigen detection in management of hepatitis C: A critical review. J Clin Virol 2005,32(2),92-101","journal-title":"J Clin Virol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep.20032","volume":"39","author":"Penin F.","year":"2004","unstructured":"Penin F.; Dubuisson J.; Rey F.A.; Moradpour D.; Pawlotsky J.M.; Structural biology of hepatitis C virus. Hepatology 2004,39(1),5-19","journal-title":"Hepatology"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1038\/sj.cdd.4401121","volume":"10","author":"Giannini C.","year":"2003","unstructured":"Giannini C.; Br\u00e9chot C.; Hepatitis C virus biology. Cell Death Differ 2003,10(S1),S27-S38","journal-title":"Cell Death Differ"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2893.1999.t01-1-6120131.x","volume":"6","author":"G\u00f3mez J.","year":"1999","unstructured":"G\u00f3mez J.; Martell M.; Quer J.; Cabot B.; Esteban J.I.; Hepatitis C viral quasispecies. J Viral Hepat 1999,6(1),3-16","journal-title":"J Viral Hepat"},{"key":"ref=83","first-page":"93","volume":"58","author":"Budkowska A.","year":"2009","unstructured":"Budkowska A.; Mechanism of cell infection with hepatitis C virus (HCV)--a new paradigm in virus-cell interaction. Pol J Microbiol 2009,58(2),93-98","journal-title":"Pol J Microbiol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1099\/vir.0.027987-0","volume":"92","author":"Jo J.","year":"2011","unstructured":"Jo J.; Lohmann V.; Bartenschlager R.; Thimme R.; Experimental models to study the immunobiology of hepatitis C virus. J Gen Virol 2011,92(3),477-493","journal-title":"J Gen Virol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"20160274","DOI":"10.1098\/rstb.2016.0274","volume":"372","author":"Ringelhan M","year":"1737","unstructured":"Ringelhan M; McKeating JA; Protzer U; Viral hepatitis and liver cancer. Philos Trans R Soc Lond B Biol Sci 1737,372(1732),20160274","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-642-38965-8_7","volume":"193","author":"Lim E.J.","year":"2014","unstructured":"Lim E.J.; Torresi J.; Prevention of hepatitis C virus infection and liver cancer. Recent Results Cancer Res 2014,193,113-133","journal-title":"Recent Results Cancer Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"e0227082","DOI":"10.1371\/journal.pone.0227082","volume":"15","author":"Nutini M.F.R.","year":"2020","unstructured":"Nutini M.F.R.; Hunter J.; Giron L.; Pires A.F.N.P.C.; Kohiyama I.M.; Camargo M.; Sucupira M.C.A.; Benzaken A.S.; Ferreira P.A.; Truong H.H.M.; Diaz R.S.; HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country. PLoS One 2020,15(1),e0227082","journal-title":"PLoS One"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","volume":"61","author":"Messina J.P.","year":"2015","unstructured":"Messina J.P.; Humphreys I.; Flaxman A.; Brown A.; Cooke G.S.; Pybus O.G.; Barnes E.; Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015,61(1),77-87","journal-title":"Hepatology"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/apt.14646","volume":"47","author":"Sadler M.D.","year":"2018","unstructured":"Sadler M.D.; Editorial: Genotype 3  -who still needs ribavirin in a pan-genotypic era? Aliment Pharmacol Ther 2018,47(11),1548-1549","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/5584_2018_190","volume":"1096","author":"Janiak M.","year":"2018","unstructured":"Janiak M.; Caraballo Cort\u00e9s K.; Perlejewski K.; Kubicka-Russel D.; Grabarczyk P.; Demkow U.; Radkowski M.; Next-generation sequencing of Hepatitis C Virus (HCV) mixed-genotype infections in anti-HCV-negative blood donors. Adv Exp Med Biol 2018,1096,65-71","journal-title":"Adv Exp Med Biol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"401","DOI":"10.18926\/AMO\/56178","volume":"72","author":"Wada N.","year":"2018","unstructured":"Wada N.; Ikeda F.; Mori C.; Takaguchi K.; Fujioka S.I.; Kobashi H.; Morimoto Y.; Kariyama K.; Sakaguchi K.; Hashimoto N.; Moriya A.; Kawaguchi M.; Miyatake H.; Hagihara H.; Kubota J.; Takayama H.; Takeuchi Y.; Yasunaka T.; Takaki A.; Iwasaki Y.; Okada H.; Mixed HCV infection of genotype 1B and other genotypes influences non-response during daclatasvir + asunaprevir combination therapy. Acta Med Okayama 2018,72(4),401-406","journal-title":"Acta Med Okayama"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","volume":"69","author":"Pawlotsky J-M.","year":"2018","unstructured":"Pawlotsky J-M.; Negro F.; Aghemo A.; Berenguer M.; Dalgard O.; Dusheiko G.; Marra F.; Puoti M.; Wedemeyer H.; EASL recommendations on treatment of hepatitis C 2018. J Hepatol 2018,69(2),461-511","journal-title":"J Hepatol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cid\/cit226","volume":"57","author":"Sullivan J.C.","year":"2013","unstructured":"Sullivan J.C.; De Meyer S.; Bartels D.J.; Dierynck I.; Zhang E.Z.; Spanks J.; Tigges A.M.; Ghys A.; Dorrian J.; Adda N.; Martin E.C.; Beumont M.; Jacobson I.M.; Sherman K.E.; Zeuzem S.; Picchio G.; Kieffer T.L.; Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials. Clin Infect Dis 2013,57(2),221-229","journal-title":"Clin Infect Dis"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","volume":"65","author":"Conti F.","year":"2016","unstructured":"Conti F.; Buonfiglioli F.; Scuteri A.; Crespi C.; Bolondi L.; Caraceni P.; Foschi F.G.; Lenzi M.; Mazzella G.; Verucchi G.; Andreone P.; Brillanti S.; Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol 2016,65(4),727-733","journal-title":"J Hepatol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/liv.14226","volume":"40","author":"Amaddeo G.","year":"2020","unstructured":"Amaddeo G.; Nguyen C.T.; Maill\u00e9 P.; Mul\u00e9 S.; Luciani A.; Machou C.; Rodrigues A.; Regnault H.; Mallat A.; Laurent A.; Lafdil F.; H\u00e9zode C.; Pawlotsky J.M.; Calderaro J.; Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy. Liver Int 2020,40(1),74-82","journal-title":"Liver Int"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3390\/medicina59040814","volume":"59","author":"Garc\u00eda-Ros A.","year":"2023","unstructured":"Garc\u00eda-Ros A.; Mor\u00e1n S.; N\u00fa\u00f1ez V.; Garc\u00eda-Ros G.; Ruiz G.; Garc\u00eda-Solano J.; Impact of direct-acting antiviral therapy on liver fibrosis regression among people with chronic HCV infection: Results from a real-life cohort in patients who achieved sustained virological response. Medicina 2023,59(4),814","journal-title":"Medicina"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jcv.2004.03.019","volume":"31","author":"Raghuraman S.","year":"2004","unstructured":"Raghuraman S.; Abraham P.; Sridharan G.; Daniel H.D.; Ramakrishna B.S.; Shaji R.V.; HCV genotype 4\u2014an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol 2004,31(4),253-258","journal-title":"J Clin Virol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1111\/apt.14648","volume":"47","author":"von Felden J.","year":"2018","unstructured":"von Felden J.; Vermehren J.; Schulze zur Wiesch J.; Sarrazin C.; Christensen S.; Editorial: Genotype 3  -who still needs ribavirin in a pan-genotypic era? Authors\u2019 reply. Aliment Pharmacol Ther 2018,47(11),1550-1551","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"e0122082","DOI":"10.1371\/journal.pone.0122082","volume":"10","author":"Qiu P.","year":"2015","unstructured":"Qiu P.; Stevens R.; Wei B.; Lahser F.; Howe A.Y.M.; Klappenbach J.A.; Marton M.J.; HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma. PLoS One 2015,10(4),e0122082","journal-title":"PLoS One"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.3390\/v13091721","volume":"13","author":"Lapointe H.R.","year":"2021","unstructured":"Lapointe H.R.; Dong W.; Dong W.W.Y.; Kirkby D.; Woods C.; Poon A.F.Y.; Howe A.Y.M.; Harrigan P.R.; Brumme C.J.; Validation of a genotype-independent hepatitis C virus near-whole genome sequencing assay. Viruses 2021,13(9),1721","journal-title":"Viruses"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"e00060-19","DOI":"10.1128\/JCM.00060-19","volume":"57","author":"Peiffer K.H.","year":"2019","unstructured":"Peiffer K.H.; Kuhnhenn L.; Stelzl E.; Dietz J.; Susser S.; Tal A.O.; Finkelmeier F.; Zuckerman E.; Cornberg M.; Barak M.; Piazzolla V.; Mangia A.; Zeuzem S.; Kessler H.H.; Vermehren J.; Sarrazin C.; Performance of three common Hepatitis C Virus (HCV) genotyping assays for identification of HCV genotype 2\/1 chimeras. J Clin Microbiol 2019,57(7),e00060-19","journal-title":"J Clin Microbiol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4149\/av_2021_405","volume":"65","author":"Zahid N.","year":"2022","unstructured":"Zahid N.; Ahmad R.; Iqbal M.S.; Khan S.A.; Asghar S.Y.; Shah M.M.; Detection of hepatitis through proteases and protease inhibitors genes expression and identification of HCV untypable genotype in Abbottabad, Pakistan. Acta Virol 2022,65(4),390-401","journal-title":"Acta Virol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1128\/JCM.01982-06","volume":"45","author":"Bouchardeau F.","year":"2007","unstructured":"Bouchardeau F.; Cantaloube J.F.; Chevaliez S.; Portal C.; Razer A.; Lefr\u00e8re J.J.; Pawlotsky J.M.; De Micco P.; Laperche S.; Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol 2007,45(4),1140-1145","journal-title":"J Clin Microbiol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1365-2036.2011.04714.x","volume":"34","author":"Chao D.T.","year":"2011","unstructured":"Chao D.T.; Abe K.; Nguyen M.H.; Systematic review: Epidemiology of hepatitis C genotype 6 and its management. Aliment Pharmacol Ther 2011,34(3),286-296","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"e0207584","DOI":"10.1371\/journal.pone.0207584","volume":"13","author":"Bouacida L.","year":"2018","unstructured":"Bouacida L.; Suin V.; Hutse V.; Boudewijns M.; Cartuyvels R.; Debaisieux L.; De Laere E.; Hallin M.; Hougardy N.; Lagrou K.; Oris E.; Padalko E.; Reynders M.; Roussel G.; Senterre J.M.; Stalpaert M.; Ursi D.; Vael C.; Vaira D.; Van Acker J.; Verstrepen W.; Van Gucht S.; Kabamba B.; Quoilin S.; Muyldermans G.; Distribution of HCV genotypes in Belgium from 2008 to 2015. PLoS One 2018,13(12),e0207584","journal-title":"PLoS One"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"e29545","DOI":"10.1097\/MD.0000000000029545","volume":"101","author":"Su R.","year":"2022","unstructured":"Su R.; Dong L.; Wang Y.; Sa R.; Wang Y.; Distribution of hepatitis C virus genotype and subtype between Mongolian and Han in Inner Mongolia. medicine 2022,101(28),e29545","journal-title":"medicine"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.diagmicrobio.2017.12.024","volume":"91","author":"Sridhar S.","year":"2018","unstructured":"Sridhar S.; Yip C.C.Y.; Chan J.F.W.; To K.K.W.; Cheng V.C.C.; Yuen K.Y.; Impact of inter-genotypic recombination and probe cross-reactivity on the performance of the Abbott RealTime HCV Genotype II assay for hepatitis C genotyping. Diagn Microbiol Infect Dis 2018,91(1),34-37","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3748\/wjg.v20.i11.2927","volume":"20","author":"Thong V.D.","year":"2014","unstructured":"Thong V.D.; Akkarathamrongsin S.; Poovorawan K.; Tangkijvanich P.; Poovorawan Y.; Hepatitis C virus genotype 6: Virology, epidemiology, genetic variation and clinical implication. World J Gastroenterol 2014,20(11),2927-2940","journal-title":"World J Gastroenterol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/iub.201","volume":"61","author":"Vassilaki N.","year":"2009","unstructured":"Vassilaki N.; Mavromara P.; The HCV ARFP\/F\/core+1 protein: Production and functional analysis of an unconventional viral product. IUBMB Life 2009,61(7),739-752","journal-title":"IUBMB Life"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/cells10030538","volume":"10","author":"Pe\u00f1a-Asensio J.","year":"2021","unstructured":"Pe\u00f1a-Asensio J.; Calvo H.; Torralba M.; Miquel J.; Sanz-de-Villalobos E.; Larrubia J.R.; Gamma-Chain Receptor Cytokines and PD-1 Manipulation to Restore HCV-Specific CD8 T Cell Response during Chronic Hepatitis C. Cells 2021,10(3),538","journal-title":"Cells"},{"key":"ref=111","first-page":"198","volume":"64","author":"Chalupa P.","year":"2015","unstructured":"Chalupa P.; Holub M.; Davidov\u00e1 A.; Arientov\u00e1 S.; Beran O.; Imunitn\u00ed odpov\u011b\u010f v patogenezi infekce virem hepatitidy C. Epidemiol Mikrobiol Imunol 2015,64(4),198-203","journal-title":"Epidemiol Mikrobiol Imunol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2217\/hep-2017-0019","volume":"4","author":"Sengupta S.","year":"2017","unstructured":"Sengupta S.; Parikh N.D.; Biomarker development for hepatocellular carcinoma early detection: Current and future perspectives. Hepat Oncol 2017,4(4),111-122","journal-title":"Hepat Oncol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"Bruix J.","year":"2011","unstructured":"Bruix J.; Sherman M.; Management of hepatocellular carcinoma: An update. Hepatology 2011,53(3),1020-1022","journal-title":"Hepatology"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/biomedicines8120576","volume":"8","author":"Pan Y.","year":"2020","unstructured":"Pan Y.; Chen H.; Yu J.; Biomarkers in hepatocellular carcinoma: Current status and future perspectives. Biomedicines 2020,8(12),576","journal-title":"Biomedicines"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.acc.2015.03.001","volume":"70","author":"Park S.H.","year":"2015","unstructured":"Park S.H.; Bang C.S.; Kim D.J.; Biomarkers in HCV infection. Adv Clin Chem 2015,70,131-196","journal-title":"Adv Clin Chem"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501265769231020031857","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/222858\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501265769231020031857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T12:07:10Z","timestamp":1704715630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/222858\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":115,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501265769231020031857","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}